Related Experiment Video
Updated: Aug 29, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Targets for molecular therapy of skin cancer
Cheryl L Green1, Paul A Khavari
1Program in Epithelial Biology, Stanford University School of Medicine, 269 Campus Drive, Room 2145, Stanford, CA 94305, USA.
Abstract:
Cancers of the skin encompass the first and second most common neoplasms in the United States, epidermal basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), respectively, as well as the melanocytic malignancy, malignant melanoma (MM). Recently identified alterations in the function of specific genes in these cancers provide new potential therapeutic targets. These alterations affect conserved regulators of cellular proliferation and viability, including the Sonic Hedgehog, Ras/Raf, ARF/p53, p16(INK4A)/CDK4/Rb and NF-kappaB pathways. New modalities designed to target these specific proteins may represent promising approaches to therapy of human skin cancers.
Insights
Skin cancers like basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are common. Gene alterations in these cancers offer new therapeutic targets by affecting key cellular pathways, paving the way for novel treatments.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma (MM) are the most common skin cancers in the US.
- Recent research has identified specific genetic alterations in these neoplasms.
Purpose of the Study:
- To explore the role of identified genetic alterations in the development of skin cancers.
- To identify potential therapeutic targets based on these genetic alterations.
Main Methods:
- Analysis of genetic alterations in skin cancer cells.
- Investigation of the impact of these alterations on cellular proliferation and viability pathways.
Main Results:
- Identified alterations in conserved regulators of cellular proliferation and viability.
- Highlighted the involvement of Sonic Hedgehog, Ras/Raf, ARF/p53, p16(INK4A)/CDK4/Rb, and NF-kappaB pathways.
Conclusions:
- Specific gene alterations in skin cancers provide novel therapeutic targets.
- Targeting these altered proteins may offer promising new treatment strategies for human skin cancers.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer

